• Chlordiazepoxide, Urine
  • Ehrlichia chaffeensis Antibody, IgG and IgM
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • Oncomine™ Dx Target Test for Non–Small Cell Lung Cancer (NSCLC) and Other Cancer Treatment Monitoring
  • Biopsy, Mediastinal Lymph Node
  • Wound Pathogen Panel with Antibiotic Resistance by Molecular
  • 11-Deoxycorticosterone, Quantitative, Serum
  • Microsporidia species, Molecular Detection, PCR
  • Cystic Fibrosis (CFTR) Gene Mutation Analysis
  • Coxsackie B (1-6) Antibodies, (CSF)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Osteogenesis Imperfecta and Low Bone Density Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Osteogenesis Imperfecta and Low Bone Density Gene Mutation Panel, NGS
Medical Test

Reference Ranges
Access to Osteogenesis Imperfecta and Low Bone Density Gene Mutation Panel, NGS is restricted.
Loading...